Xalles Holdings Inc. (OTC: XALL), an industry-leading fintech holding company specializing in innovative technology and financial service solutions, today is providing a series of updates to shareholders.
With innovation at our core, Xalles is excited to spotlight the transformation of our business model to RISE, the acronym for "Roll In, Selected Exit." Since its introduction in August, the model has received a positive reception from potential target acquisition companies as well as potential investors. It has assisted us in advancing many of the deals in the acquisition pipeline. Expect a suite of announcements regarding these acquisitions in the coming weeks.
Charting our path forward, Xalles has undertaken a significant fundraising expedition. This dual-pronged initiative will first tap into private financing and then proceed with a Reg A+ offering. As a testament to our growth trajectory, we're adjusting our total authorized common stock, transitioning from two billion to five billion shares of common stock – the only increase since September 2019. We anticipate this to solidify our position for years to come and want to emphasize that no reverse split of the common stock is a part of our plans.
Xalles has recently amicably divested its stake in Patient Healthcare Solutions, Inc. ("PHCS"). This transition sees PHCS returning to its original shareholders. While our collaboration didn't yield the anticipated revenue, we commend the PHCS team on their new journey. As always, Xalles is in continuous pursuit of opportunities that promise financial innovation, especially in the healthcare domain. This transaction will not affect the financial results in 2023.
About Xalles Holdings Inc. (OTC: XALL)
Xalles Holdings Inc. is a holding company that focuses on direct investments in disruptive fintech companies. The company actively seeks acquisition targets in which it can invest and accelerate growth, targeting companies with solid management teams and business models, large total attainable markets (TAM), and lucrative exit opportunities. The company places emphasis on leveraging blockchain and other technologies to provide industry-leading financial reconciliation and auditing solutions, which, over time, will allow for the capture of recurring revenue streams. For more information visit: Xalles.com.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at SEC.gov and in OTC Markets at OTCMarkets.com.
Investor Relations Contact:
IR@xalles.com
IR: 202.779.1460